# BlackBarn Capital Partners LP

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 2010204. Source: https://holderbook.com/funds/2010204-blackbarn-capital-partners-lp/

- Reported value: $1.2B
- Positions: 21
- Weight of the ten largest: 86.0%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| STATE STR SPDR S&P 500 ETF T | [SPY](https://holderbook.com/stocks/SPY/) | $597.4M | 0 | 50.4% | 8 |
| ROIVANT SCIENCES LTD | [ROIV](https://holderbook.com/stocks/ROIV/) | $70.8M | 2,000,000 | 6.0% | 11 |
| UNITEDHEALTH GROUP INC | [UNH](https://holderbook.com/stocks/UNH/) | $68.6M | 65,000 | 5.8% | 1 |
| VENTURE GLOBAL INC | [VG](https://holderbook.com/stocks/VG/) | $52.9M | 1,750,000 | 4.5% | 1 |
| OSCAR HEALTH INC | [OSCR](https://holderbook.com/stocks/OSCR/) | $49.9M | 0 | 4.2% | 1 |
| PRIVIA HEALTH GROUP INC | [PRVA](https://holderbook.com/stocks/PRVA/) | $40.8M | 1,585,000 | 3.4% | 11 |
| RESMED INC | [RMD](https://holderbook.com/stocks/RMD/) | $39.0M | 0 | 3.3% | 4 |
| DIVERSIFIED HEALTHCARE TR | [DHC](https://holderbook.com/stocks/DHC/) | $37.9M | 4,075,000 | 3.2% | 11 |
| VIKING THERAPEUTICS INC | [VKTX](https://holderbook.com/stocks/VKTX/) | $33.2M | 600,000 | 2.8% | 5 |
| NEXTERA ENERGY INC | [NEE](https://holderbook.com/stocks/NEE/) | $29.4M | 335,000 | 2.5% | 5 |
| NIQ GLOBAL INTELLIGENCE PLC | [NIQ](https://holderbook.com/stocks/NIQ/) | $27.2M | 2,903,862 | 2.3% | 3 |
| NXP SEMICONDUCTORS N V | [NXPI](https://holderbook.com/stocks/NXPI/) | $25.3M | 90,000 | 2.1% | 2 |
| MCGRAW HILL INC | [MH](https://holderbook.com/stocks/MH/) | $23.2M | 2,450,000 | 2.0% | 4 |
| AMNEAL PHARMACEUTICALS INC | [AMRX](https://holderbook.com/stocks/AMRX/) | $22.5M | 1,300,000 | 1.9% | 10 |
| AZUL S A | - | $15.1M | 1,684,188 | 1.3% | 1 |
| OCCIDENTAL PETE CORP | [OXY](https://holderbook.com/stocks/OXY/) | $12.1M | 250,000 | 1.0% | 1 |
| WARBY PARKER INC | [WRBY](https://holderbook.com/stocks/WRBY/) | $12.1M | 0 | 1.0% | 4 |
| ARBUTUS BIOPHARMA CORP | [ABUS](https://holderbook.com/stocks/ABUS/) | $12.0M | 2,500,000 | 1.0% | 10 |
| CALIFORNIA RES CORP | [CRC](https://holderbook.com/stocks/CRC/) | $9.3M | 175,000 | 0.8% | 1 |
| COGENT COMM HOLDINGS INC | [CCOI](https://holderbook.com/stocks/CCOI/) | $3.5M | 250,000 | 0.3% | 6 |
| VIVID SEATS INC | [SEAT](https://holderbook.com/stocks/SEAT/) | $3.3M | 500,000 | 0.3% | 2 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +26.8% | +14.8% | +12.0% | 97% |
| Q1 2026 | +5.2% | -4.6% | +9.8% | 100% |
| Q4 2025 | +16.6% | +2.4% | +14.2% | 100% |
| Q3 2025 | +18.6% | +7.8% | +10.8% | 100% |
| Q2 2025 | +2.5% | +10.5% | -7.9% | 100% |
| Q1 2025 | -5.1% | -4.6% | -0.6% | 100% |
| Q4 2024 | -5.6% | +2.1% | -7.8% | 100% |
| Q3 2024 | +13.1% | +5.4% | +7.7% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $1.2B | 21 |
| Q1 2026 | $1.2B | 20 |
| Q4 2025 | $1.5B | 16 |
| Q3 2025 | $1.4B | 20 |
| Q2 2025 | $1.7B | 23 |
| Q1 2025 | $1.6B | 22 |
| Q4 2024 | $1.8B | 17 |
| Q3 2024 | $761.0M | 20 |
| Q2 2024 | $1.1B | 21 |
| Q1 2024 | $176.9M | 23 |
| Q4 2023 | $276.6M | 22 |